Aceto Corporation (ACET.O)
5.07USD
9 Feb 2010
$0.14 (+2.84%)
$5.07
--
$5.13
$4.88
280,727
177,545
$9.26
$4.80
About
Overall
| Beta: | 0.87 |
| Market Cap (Mil.): | $125.63 |
| Shares Outstanding (Mil.): | 24.78 |
| Annual Dividend: | 0.20 |
| Yield (%): | 3.94 |
Financials
| ACET.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 24.97 | 0.67 | 2.48 |
| EPS (TTM): | -69.90 | -- | -- |
| ROI: | 3.20 | 0.24 | 0.28 |
| ROE: | 3.55 | 0.41 | 0.44 |
UPDATE 1-EXCLUSIVE-Chemicals co Albaugh up for sale-sources
NEW YORK, July 30 (Reuters) - Albaugh, the privately owned chemicals company, has put itself up for sale and started a formal auction to find a buyer, industry sources said on Wednesday.
Aceto Corp cuts Q2 earnings view, shares drop
Jan 25 (Reuters) - Aceto Corp , a distributor of bulk generic drugs and chemicals, cut its second-quarter earnings outlook partly due to an expected drop in operating income from its non-U.S. units, and a weak U.S. dollar, sending shares down as much as 23 percent to a new year-low.
Aceto Corp Q1 results
ACETO CORP : * Aceto corporation announces 6 percent increase in operating income compared to year ago quarter * Quarterly earnings per share $0.05 * Forecasts second quarter 2008 earnings per share about $0.07 * First quarter sales rose 6.4 percent to $79.5 million * Reuters Estimates first quarter earnings per share view $0.13, revenue view $83.99 million * Reuters Estimates second quarter earnings per share view $0.11
TABLE-UPDATE 1-Aceto Q4 earnings rise
ACETO CORP (in $) Latest Yr-ago qtr EPS (diluted) 0.17 0.12 Net (million) 4.2 3.0 Net sales (million) 87.2 71.9 Reuters Estimates: EPS $0.13 (one analyst), revenue $81.4 million (one analyst)
TABLE-Aceto Q4 earnings rise
ACETO CORP (in $) Latest Yr-ago qtr EPS (diluted) 0.17 0.12 Net (million) 4.2 3.0 Net sales (million) 87.2 71.9 Reuters Estimates: EPS $0.13 (one analyst), revenue $81.4 million (one analyst) (Reporting by Anirvan Ghosh in Bangalore)
Aceto to redo testing for companion animal vaccine
July 24 (Reuters) - Aceto Corp. said it will have to redo animal testing for its companion animal vaccine after a revision of the testing protocol.
Competitors
| Price | Change | |
|---|---|---|
| Nalco Holding Company (NLC.N) | $21.98 | +0.04 |
| Ferro Corporation (FOE.N) | $7.28 | +0.23 |
| American Vanguard Corp. (AVD.N) | $6.68 | -0.14 |
| The LGL Group, Inc. (LGL.A) | $4.05 | 0.00 |





Earnings vs
Estimates